Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
In4Derm
Dundee, Scotland, United Kingdomin4derm.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
In4Derm was a drug discovery company focused on developing first-in-class, selective BET inhibitors for anti-inflammatory and orphan indications. Its assets progressed through pre-clinical development and were licensed to VYNE Therapeutics for further clinical development. While In4Derm achieved early-stage discovery success, its programs were transitioned to partners, and the company is no longer active under its original name, having effectively been acquired or rebranded and shifting its focus.
- Therapeutic areas
- ImmunologyDermatologyRare Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
VYNE Therapeutics
Beyond the preview
Go deeper on In4Derm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on In4Derm.